NCT05555550 - Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions

GliomaLow-grade GliomaLow Grade Glioma of BrainGlioma, MalignantGlioma Intracranial

Interventions

DRUG

18F-Fluciclovine

18F-Fluciclovine will be injected via IV prior to PET-MRI imaging

Trial Locations (1)

RECRUITING

The Children s Hospital of Philadelphia, Philadelphia